Biotech

All Articles

Novo Nordisk centers once-monthly GLP-1\/ GIP agonist, MASH prospect

.Novo Nordisk has axed its once-monthly twin GLP-1/ GIP receptor agonist, ending (PDF) progression o...

Daiichi pays Merck $170M to develop bronchi cancer cells T-cell engager contract

.Merck &amp Co. has actually rapidly recouped a few of the prices of its Javelin Rehabs acquistion, ...

BioMarin stops preclinical genetics therapy for heart disease

.After BioMarin administered a springtime tidy of its own pipeline in April, the provider has actual...

Eisai plants molecular adhesive SEED along with $1.5 B biobucks deal

.Major Pharmas stay caught to the idea of molecular glue degraders. The most recent provider to view...

Life science credit agency unveils along with $600M

.A brand new worldwide lifestyle science credit rating company, termed Symbiotic Funds, has actually...

BMS trenches TIGIT, bowing out $200M bank on Agenus bispecific

.Bristol Myers Squibb is axing an additional big wager coming from the Caforio time, canceling a pac...

Nuvation halts BET inhibitor after taking into consideration phase 1 data

.After looking at period 1 data, Nuvation Bio has determined to stop work on its single top BD2-sele...

' Scientific intuition' led FDA advisors to back Zevra's rare disease med

.Zevra Rehabs' unusual ailment medication appears to become on the pathway to confirmation this fall...

Pfizer takes $230M attacked after axing failed DMD genetics treatment

.Pfizer's period 3 Duchenne muscular dystrophy (DMD) gene treatment failure has gone a $230 thousand...

AC Immune views 'spots' potential in Alzheimer's drug information

.After greater than twenty years of work on neurodegenerative health conditions, Swiss biotech hvac ...